PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 6:53 AM ET

Sponsor Check › Person

MK
No photo found yet (own website and image search run after this page is viewed)

Michael Kranda

Named as an officer, director or promoter on SEC Form D filings · WA, NJ · Jun 13, 2012 → May 15, 2013

3deals (issuers)
$202.4Mreported sold
123investors
8Form D filings
2012–2013years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Kranda is listed as an executive officer, director, and promoter on 8 SEC Form D filings by 3 issuers between Oct 2009 and Jun 2016: PTC THERAPEUTICS, INC. (South Plainfield, NJ — biotechnology — 2009–2013; $150M reported sold to 57 investors), TwinStrand Biosciences, Inc. (Seattle, WA — other technology — 2016; $50M reported sold to 45 investors) and BEAT BioTherapeutics Corp (Bellevue, WA — biotechnology — 2013; $2.4M reported sold to 21 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, director, and promoter, over about 7 years. Across those companies the filings report $202.4M sold in total.

Listed alongside Allan S. Jacobson (6 shared filings), Axel Bolte (6 shared filings), David P. Southwell (6 shared filings), Mark E. Boulding (6 shared filings), Michael Schmertzler (6 shared filings) and 21 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 8 public filings for Michael Kranda and found 6 differences: 5 offerings have no amendment in the last 12 months and may still be open; Offering amount changed between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Kranda has not run yet — it is joining a line of 21,442 names; searches run around the clock at the hosts' allowed rate. Searched so far: 363 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Kranda..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

6 differences found between the filings for Michael Kranda (compared 8 filings on Oct 24, 2026)

Note · Sep 22, 2009 – Jun 24, 2016

5 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — TwinStrand Biosciences, Inc. (latest filing Jun 24, 2016) · No amendment in the last 12 months on an offering that may still be open — BEAT BioTherapeutics Corp (latest filing Apr 16, 2013) · No amendment in the last 12 months on an offering that may still be open — PTC THERAPEUTICS, INC. (latest filing Feb 12, 2013) · No amendment in the last 12 months on an offering that may still be open — PTC THERAPEUTICS, INC. (latest filing Jun 13, 2012) · No amendment in the last 12 months on an offering that may still be open — PTC THERAPEUTICS, INC. (latest filing Dec 22, 2009)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Oct 7, 2009 – Dec 22, 2009

Offering amount changed between filings — PTC THERAPEUTICS, INC.

The Oct 7, 2009 filing says $1,000,000 offered; the Dec 22, 2009 Form D says $50,300,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Oct 7, 2009 – Jun 13, 2012

Reported revenue range changed between filings — PTC THERAPEUTICS, INC.

"$25,000,001 - $100,000,000" (Oct 7, 2009); then "Decline to Disclose" (Jun 13, 2012).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
Note · Oct 14, 2010 – Jun 3, 2011

Same name, different state: "Michael Kranda" (MD) is a separate record

This page covers filings where the address state is WA or NJ. A separate record, "Michael Kranda" with address state MD, is listed on 2 filings — most recently by VACCINOGEN INC (Jun 3, 2011). The two records do not overlap in time: this page runs Jun 13, 2012 to May 15, 2013; the other runs Oct 14, 2010 to Jun 3, 2011.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Feb 2, 2009 – Oct 2, 2009

Same name, different state: "Michael L. Kranda" (CA) is a separate record

This page covers filings where the address state is WA or NJ. A separate record, "Michael L. Kranda" with address state CA, is listed on 3 filings — most recently by ANESIVA, INC. (Oct 2, 2009). The two records do not overlap in time: this page runs Jun 13, 2012 to May 15, 2013; the other runs Feb 2, 2009 to Oct 2, 2009.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Oct 7, 2009 – Jun 24, 2016

Michael Kranda is listed with 2 different address states: WA, NJ

WA on 4 filings (Oct 7, 2009 to Jun 24, 2016); NJ on 4 filings (Jun 13, 2012 to May 15, 2013).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 7 offerings report sales commissions totalling $3,464,970; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 24, 2016 D
TwinStrand Biosciences, Inc.
File 021-265745
$0$0$0None listed on this filingEDGAR ↗
May 15, 2013 D
PTC THERAPEUTICS, INC.
File 021-196557
$315,000$0$0Credit Suisse Securities (USA) LLC BrokerCheck CRD 816 ↗
Wedbush Securities Inc. BrokerCheck CRD 877 ↗
EDGAR ↗
Apr 16, 2013 D
BEAT BioTherapeutics Corp
File 021-195092
$0$0$0None listed on this filingEDGAR ↗
Mar 21, 2013 D
PTC THERAPEUTICS, INC.
File 021-193682
$3,149,970$0$0Credit Suisse Securities (USA) LLC BrokerCheck CRD 816 ↗
Wedbush Securities Inc. BrokerCheck CRD 877 ↗
EDGAR ↗
Feb 12, 2013 D
PTC THERAPEUTICS, INC.
File 021-191684
$0$0$0None listed on this filingEDGAR ↗
Jun 13, 2012 D
PTC THERAPEUTICS, INC.
File 021-179680
$0$0$0None listed on this filingEDGAR ↗
Dec 22, 2009 D
PTC THERAPEUTICS, INC.
File 021-61608
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Michael Kranda on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

TwinStrand Biosciences, Inc.

Seattle, WA · Jun 24, 2016
  • Jun 24, 2016 · D · $1,938,964 sold of $2,270,000 · 18 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗

Raised $50M from 45 investors (100% of the $2.27M target) as of the latest filing. Michael is listed as executive officer, director, promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

PTC THERAPEUTICS, INC.

South Plainfield, NJ · Oct 7, 2009 → May 15, 2013 · 6 filings
  • May 15, 2013 · D · $4,500,000 sold of $4,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 21, 2013 · D · $59,999,448 sold of $59,999,448 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 12, 2013 · D · $2,000,100 sold of $16,100,100 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 13, 2012 · D · $22,950,840 sold of $40,000,000 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2009 · D · $25,150,064 sold of $50,300,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 7, 2009 · D · $0 sold of $1,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $150M from 57 investors (100% of the $4.5M target) as of the latest filing. Michael is listed as director on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Biotechnology

BEAT BioTherapeutics Corp

Bellevue, WA · Apr 16, 2013
  • Apr 16, 2013 · D · $2,400,000 sold of $2,500,000 · 21 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $2.4M from 21 investors (96% of the $2.5M target) as of the latest filing. Michael is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Michael L. Kranda — CA, 1 issuer, Feb 2, 2009 → Oct 2, 2009 · no shared issuer
  • Michael Kranda — MD, 1 issuer, Oct 14, 2010 → Jun 3, 2011 · no shared issuer

People around Michael 26

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Axel Bolte

Director · 6 shared filings (1 issuer) · also on 5 other issuers

Axel Bolte is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David P. Southwell

Director · 6 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Stuart W. Peltz

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Mark E. Boulding

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

AJ
No photo found yet (own website and image search run after this page is viewed)
Person

Allan S. Jacobson

Director · 6 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Schmertzler

Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Kranda. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Soren Carlsen

Director · 4 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Claudia Hirawat

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl Goldfischer

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Carl Goldfischer is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Deepa Pakianathan

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

Jerome B. Zeldis

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Kranda. Their page shows their other deals.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Geoffrey McDonough

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Svennilson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Aldrich

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Koppel

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Kranda. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

William Baird, III

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Chad Waite

Director · 1 shared filing (1 issuer) · also on 11 other issuers

Chad Waite is on 12 issuers in total — a repeat sponsor. Their page lists every one.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Langdon L. Miller

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Langon L. Miller

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Leggett

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Tall

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Kranda. Their page shows their other deals.

GD
No photo found yet (own website and image search run after this page is viewed)
Person

Greg Mahairas, Ph.D.

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jesse Salk

Director, Promoter · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Kranda. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Schmitt

Director, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

LR
No photo found yet (own website and image search run after this page is viewed)
Person

Linden Rhoads

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Kranda. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence Loeb

Director, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Michael Kranda. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Kranda by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Kranda is listed on: none on file. No website or social profile named in BEAT BioTherapeutics Corp's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #331,485 of 374,652 in line (561 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Bellevue, WA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Kranda appears on a new Form D, or when a court case or SEC action is matched to them. See plans →